Recent studies show that when people used the medication Elmiron long-term, they experienced maculopathy, an eye disorder that can cause permanent blindness. Several patients who took Elmiron developed pigmentary maculopathy, according to doctors who have studied the drug. A study from The American Academy of Ophthalmology reported that patients were recommended to have their eyes examined while still on the medication to see if they have maculopathy. If they did, they needed to stop taking it right away. Patients are suing Janssen Pharmaceuticals, the drug manufacturer because the company failed to warn them about the possible dangers associated with the drug.
Patients who have taken Elmiron and suffered severe side effects will need an experienced dangerous drugs lawyer to help them with their case. The Guardian Legal Network can connect Elmiron victims with experienced law firms.